Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide). The Company is working with Hims ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

Healthcare & Pharmaceuticalscategory· April 11, 2025 US FDA approves syringe version of Argenx's immune disorder drug The U.S. Food and Drug Administration has approved a prefilled syringe ...

Halozyme Therapeutics, Inc. (Halozyme) announced that argenx has received US Food and Drug Administration (FDA) approval of Vyvgart Hytrulo prefilled syringe for self-injection ... for itself or with ...